hydroxyproline has been researched along with praziquantel in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (23.08) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Emonard, H; Grimaud, JA | 1 |
| Ge, SD; Lu, ML; Ma, DY; Wei, CC; Xu, ML; Xu, PP; Xu, ZY | 1 |
| Dunn, MA; Girgis, NI; Ishak, EA; Khayyal, MT; Mansour, MM; Morcos, SH; Saleh, S | 1 |
| Andrade, ZA; Cheever, AM; Cox, TM | 1 |
| Afify, HA; el-Shafei, MM; Mattar, MA | 1 |
| Boros, DL; Gerard, HC; Hudson, AP; Singh, KP | 1 |
| Daxnerová, Z; Hrckova, G; Solár, P; Velebný, S | 1 |
| Boonmars, T; Hiraku, Y; Pinlaor, P; Pinlaor, S; Prakobwong, S; Wongkham, C | 1 |
| Chen, AL; Liang, YJ; Liu, YP; Luo, J; Ren, YY; Shi, L; Sun, KY; Sun, Y; Wang, Y; Yuan, Q; Zhang, ZS; Zheng, D; Zhou, Y | 1 |
| Ain-Shoka, A; Badawy, A; Ebeid, F; El-Lakkany, NM; El-Maadawy, W; Hammam, O | 1 |
| Ebeid, F; el-Din, SS; El-Lakkany, N | 1 |
| Ain-Shoka, AA; Badawy, AA; Ebeid, FA; El-Lakkany, NM; El-Maadawy, WH; Hammam, OA | 1 |
| Ashour, RH; Elhenawy, AA; Megahed, N; Nabih, N; Shalaby, NM | 1 |
13 other study(ies) available for hydroxyproline and praziquantel
| Article | Year |
|---|---|
Active and latent collagenase activity during reversal of hepatic fibrosis in murine schistosomiasis.
Topics: Animals; Female; Hydroxyproline; Liver; Liver Cirrhosis, Experimental; Mice; Microbial Collagenase; Praziquantel; Schistosomiasis | 1989 |
[Significance of determination of some biochemical indices in hepatic fibrosis of animal schistosomiasis japonica].
Topics: Animals; Hydroxyproline; Liver Cirrhosis, Experimental; Monoamine Oxidase; Mucoproteins; Praziquantel; Proline; Rabbits; Schistosomiasis | 1985 |
Reversal of hepatic fibrosis after praziquantel therapy of murine schistosomiasis.
Topics: Animals; Collagen; Granuloma; Hydroxyproline; Isoquinolines; Liver; Liver Diseases; Male; Mice; Organ Size; Parasite Egg Count; Praziquantel; Schistosoma mansoni; Schistosomiasis | 1985 |
Regression of hepatic lesions after treatment of Schistosoma mansoni or Schistosoma japonicum infection in mice: a comparative study.
Topics: Animals; Collagen; Granuloma; Hydroxyproline; Liver; Lung; Mice; Praziquantel; Schistosoma japonicum; Schistosoma mansoni; Schistosomiasis japonica; Schistosomiasis mansoni; Treatment Outcome | 1993 |
Parasitological and immunological changes in murine hepatic schistosomiasis before and after praziquantel treatment.
Topics: Animals; Anthelmintics; Feces; Hydroxyproline; Intestines; Liver; Liver Diseases, Parasitic; Mice; Parasite Egg Count; Praziquantel; Schistosomiasis mansoni; Severity of Illness Index | 2002 |
Expression of matrix metalloproteinases and their inhibitors during the resorption of schistosome egg-induced fibrosis in praziquantel-treated mice.
Topics: Animals; Anthelmintics; Body Weight; Cell Count; Cells, Cultured; Collagen; Cytokines; Female; Gene Expression; Hydroxyproline; Liver; Liver Cirrhosis; Matrix Metalloproteinases; Mice; Mice, Inbred CBA; Organ Size; Praziquantel; Reverse Transcriptase Polymerase Chain Reaction; Schistosomiasis mansoni; Spleen; Tissue Inhibitor of Metalloproteinases | 2004 |
Praziquantel and liposomized glucan-treatment modulated liver fibrogenesis and mastocytosis in mice infected with Mesocestoides vogae (M. corti, Cestoda) tetrathyridia.
Topics: Animals; Anthelmintics; beta-Glucans; Bromodeoxyuridine; Cestode Infections; Collagen; Drug Therapy, Combination; Hydroxyproline; Immunohistochemistry; Liposomes; Liver; Liver Cirrhosis; Male; Mast Cells; Mastocytosis; Mesocestoides; Mice; Mice, Inbred ICR; Praziquantel; Thymidine; Tolonium Chloride; Tritium | 2006 |
Effect of praziquantel treatment on the expression of matrix metalloproteinases in relation to tissue resorption during fibrosis in hamsters with acute and chronic Opisthorchis viverrini infection.
Topics: Animals; Collagen; Cricetinae; Gene Expression Profiling; Hydroxyproline; Liver; Liver Cirrhosis; Male; Matrix Metalloproteinases; Opisthorchiasis; Opisthorchis; Praziquantel; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2009 |
New insight into the antifibrotic effects of praziquantel on mice in infection with Schistosoma japonicum.
Topics: Alanine Transaminase; Animals; Anthelmintics; Aspartate Aminotransferases; Cells, Cultured; Female; Hydroxyproline; Immunohistochemistry; Liver Cirrhosis; Mice; Mice, Inbred BALB C; Polymerase Chain Reaction; Praziquantel; Schistosoma japonicum; Schistosomiasis japonica | 2011 |
Potential antifibrotic effects of AT1 receptor antagonist, losartan, and/or praziquantel on acute and chronic experimental liver fibrosis induced by Schistosoma mansoni.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anthelmintics; Disease Models, Animal; Drug Therapy, Combination; Glutathione; Granuloma; Humans; Hydroxyproline; Liver Cirrhosis, Experimental; Liver Function Tests; Losartan; Male; Matrix Metalloproteinase 2; Mice; Mice, Inbred ICR; Parasite Egg Count; Praziquantel; Schistosomiasis mansoni; Transforming Growth Factor beta1 | 2011 |
The use of pentoxifylline as adjuvant therapy with praziquantel downregulates profibrogenic cytokines, collagen deposition and oxidative stress in experimental schistosomiasis mansoni.
Topics: Animals; Collagen; Cytokines; Down-Regulation; Drug Therapy, Combination; Free Radical Scavengers; Hydroxyproline; Lipid Peroxidation; Liver; Male; Matrix Metalloproteinase 2; Mice; Oxidative Stress; Pentoxifylline; Praziquantel; Random Allocation; Schistosomiasis mansoni; Schistosomicides; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2011 |
Anti-inflammatory/anti-fibrotic effects of the hepatoprotective silymarin and the schistosomicide praziquantel against Schistosoma mansoni-induced liver fibrosis.
Topics: Animals; Drug Therapy, Combination; Hydroxyproline; Liver; Liver Cirrhosis; Liver Function Tests; Male; Mast Cells; Matrix Metalloproteinase 2; Mice; Parasite Egg Count; Praziquantel; Protective Agents; Schistosoma mansoni; Schistosomiasis mansoni; Schistosomicides; Silymarin; Transforming Growth Factor beta1 | 2012 |
Possible antifibrotic effect of GDC-0449 (Vismodegib), a hedgehog-pathway inhibitor, in mice model of Schistosoma-induced liver fibrosis.
Topics: Anilides; Animals; Cercaria; Disease Models, Animal; Drug Therapy, Combination; Egypt; Female; Hedgehog Proteins; Hydroxyproline; Liver; Liver Cirrhosis; Mice; Parasite Egg Count; Praziquantel; Pyridines; Schistosoma mansoni; Schistosomiasis mansoni | 2017 |